赣南医学院学报
贛南醫學院學報
공남의학원학보
JOURNAL OF GANNAN MEDICAL COLLEGE
2014年
6期
880-882
,共3页
叶建明%王春丽%黄莉%许明君%王祥财
葉建明%王春麗%黃莉%許明君%王祥財
협건명%왕춘려%황리%허명군%왕상재
多西他赛%顺铂%氟尿嘧啶%诱导化疗%局部晚期鼻咽癌
多西他賽%順鉑%氟尿嘧啶%誘導化療%跼部晚期鼻嚥癌
다서타새%순박%불뇨밀정%유도화료%국부만기비인암
docetaxel%cisplatin%fluorouracil%induction chemotherapy%locally advanced nasopharyngeal carcinoma
目的:评价多西他赛联合顺铂和氟尿嘧啶方案( DpF方案)诱导化疗局部晚期鼻咽癌的近期临床疗效和毒性反应。方法:对25例经病理学证实的Ⅲ、Ⅳa期初治鼻咽癌患者于第1天静脉滴注多西他赛75 mg·m-2和顺铂75 mg·m-2,氟尿嘧啶2.5 g·m-2持续静脉泵入120 h,每3周为1疗程,2疗程后行同期放化疗。同期化疗方案为顺铂40 mg·m-2每周一次。结果:25例患者中,诱导化疗后鼻咽原发灶CR 5例(20.0%)、pR 18例(72.0%)、SD 2例(8.0%),总有效率为92%;颈部转移灶CR 4例(16.0%)、pR 21例(84.0%),总有效率为100%。放化疗后CR 24例(96%)、pR 1例(4%)。毒性反应主要为骨髓抑制、口腔粘膜和胃肠道反应,Ⅲ~Ⅳ度粒细胞减少占56%,60%以上的患者出现了中度(Ⅱ、Ⅲ度)胃肠道反应,其它毒副反应少见。综合治疗完成后有1例患者出现颈部淋巴结残留,其余患者均达CR。结论:多西他赛、顺铂及5-氟尿嘧啶诱导化疗较pF方案提高了局部晚期鼻咽癌的近期疗效,而且不良反应可以接受。其近期有效率的提高是否能转化为远期疗效值得进一步研究。
目的:評價多西他賽聯閤順鉑和氟尿嘧啶方案( DpF方案)誘導化療跼部晚期鼻嚥癌的近期臨床療效和毒性反應。方法:對25例經病理學證實的Ⅲ、Ⅳa期初治鼻嚥癌患者于第1天靜脈滴註多西他賽75 mg·m-2和順鉑75 mg·m-2,氟尿嘧啶2.5 g·m-2持續靜脈泵入120 h,每3週為1療程,2療程後行同期放化療。同期化療方案為順鉑40 mg·m-2每週一次。結果:25例患者中,誘導化療後鼻嚥原髮竈CR 5例(20.0%)、pR 18例(72.0%)、SD 2例(8.0%),總有效率為92%;頸部轉移竈CR 4例(16.0%)、pR 21例(84.0%),總有效率為100%。放化療後CR 24例(96%)、pR 1例(4%)。毒性反應主要為骨髓抑製、口腔粘膜和胃腸道反應,Ⅲ~Ⅳ度粒細胞減少佔56%,60%以上的患者齣現瞭中度(Ⅱ、Ⅲ度)胃腸道反應,其它毒副反應少見。綜閤治療完成後有1例患者齣現頸部淋巴結殘留,其餘患者均達CR。結論:多西他賽、順鉑及5-氟尿嘧啶誘導化療較pF方案提高瞭跼部晚期鼻嚥癌的近期療效,而且不良反應可以接受。其近期有效率的提高是否能轉化為遠期療效值得進一步研究。
목적:평개다서타새연합순박화불뇨밀정방안( DpF방안)유도화료국부만기비인암적근기림상료효화독성반응。방법:대25례경병이학증실적Ⅲ、Ⅳa기초치비인암환자우제1천정맥적주다서타새75 mg·m-2화순박75 mg·m-2,불뇨밀정2.5 g·m-2지속정맥빙입120 h,매3주위1료정,2료정후행동기방화료。동기화료방안위순박40 mg·m-2매주일차。결과:25례환자중,유도화료후비인원발조CR 5례(20.0%)、pR 18례(72.0%)、SD 2례(8.0%),총유효솔위92%;경부전이조CR 4례(16.0%)、pR 21례(84.0%),총유효솔위100%。방화료후CR 24례(96%)、pR 1례(4%)。독성반응주요위골수억제、구강점막화위장도반응,Ⅲ~Ⅳ도립세포감소점56%,60%이상적환자출현료중도(Ⅱ、Ⅲ도)위장도반응,기타독부반응소견。종합치료완성후유1례환자출현경부림파결잔류,기여환자균체CR。결론:다서타새、순박급5-불뇨밀정유도화료교pF방안제고료국부만기비인암적근기료효,이차불량반응가이접수。기근기유효솔적제고시부능전화위원기료효치득진일보연구。
Objective:To evaluate the clinical effect and toxic reaction of docetaxel combined with cisplatin and fluoroura-cil for induction chemotherapy in the treatment of patients with locally advanced nasopharyngeal carcinoma. Methods:Twenty-five patients with locally advanced nasopharyngeal carcinoma diagnosed pathologically were injected docetaxel(75 mg·m-2 )and cisplatin( 75 mg · m-2 )on the first day they were enrolled in by intravenous dripping;fluorouracil (2. 5 g·m-2 )in 120 hours by continuous intravenous pumping for 2 courses with a course of 3 weeks. Concurrent chem-otherapy was received. Cisplatin(40 mg·m-2 )was injected once a week in the concurrent chemotherapy regimens. Re-sults:Of all the 25 patients,completed response(CR)of nasopharyngeal primary tumor was 5 cases(20. 0%),partial responses(pR)was 18 cases(72. 0%),stable disease(SD)was 2 cases(8. 0%),and overall response rate was 96. 0%;completed response(CR)of neck metastasis lymph node was 4 cases(16. 0%),partial responses(pR)was 21 cases(84. 0%),and overall response rate was 100. 0%. The main toxicity was myelosuppression and gastrointestinal re-actions,Ⅲ~Ⅳ leucopenia occurred in 56. 0% of all cases,and Ⅱ~Ⅲ gastrointestinal reactions occurred more than 60%,It was rare to have other side effects. After Comprehensive treatment,all the cases got to CR except one case with neck lymph node residues. Conclutions:Compared with pF regimen,The docetaxel combined with cisplatin and fluoroura-cil regimen increases short-term clinical effect of locally advanced nasopharyngeal carcinoma;the toxicity and side effects are well-tolerated. It is worthy of further clinical studies on whether its increased short-term effects could turn into long-term effects.